What Caught Our Attention in the Investment World? – Week of June 15 – 19, 2020
By Kuldip K. Ambastha Biogen Inc. (BIIB) had a -7.5% return on Thursday, June 18, 2020. On this day, Biogen Inc. lost a legal dispute (over a patent) being heard by a U.S. district court. The patent dispute centered on a multiple sclerosis treatment drug called Tecfidera, which uses dimethyl fumarate as its main active …
Continue reading “What Caught Our Attention in the Investment World? – Week of June 15 – 19, 2020”